DK1089719T3 - Transdermalt terapeutisk system indeholdende hormoner og krystallisationsinhibitorer - Google Patents
Transdermalt terapeutisk system indeholdende hormoner og krystallisationsinhibitorerInfo
- Publication number
- DK1089719T3 DK1089719T3 DK99927904T DK99927904T DK1089719T3 DK 1089719 T3 DK1089719 T3 DK 1089719T3 DK 99927904 T DK99927904 T DK 99927904T DK 99927904 T DK99927904 T DK 99927904T DK 1089719 T3 DK1089719 T3 DK 1089719T3
- Authority
- DK
- Denmark
- Prior art keywords
- system containing
- therapeutic system
- transdermal therapeutic
- crystallization inhibitors
- containing hormones
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/932—Specified use of nanostructure for electronic or optoelectronic application
- Y10S977/939—Electron emitter, e.g. spindt emitter tip coated with nanoparticles
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19828273A DE19828273B4 (de) | 1998-06-25 | 1998-06-25 | Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren |
PCT/EP1999/003922 WO1999066901A2 (fr) | 1998-06-25 | 1999-06-08 | Systeme therapeutique transdermique, contenant des hormones et des inhibiteurs de cristallisation |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1089719T3 true DK1089719T3 (da) | 2002-08-05 |
Family
ID=7871950
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99927904T DK1089719T3 (da) | 1998-06-25 | 1999-06-08 | Transdermalt terapeutisk system indeholdende hormoner og krystallisationsinhibitorer |
Country Status (23)
Country | Link |
---|---|
US (1) | US6899894B1 (fr) |
EP (1) | EP1089719B1 (fr) |
JP (1) | JP2002518430A (fr) |
KR (1) | KR100550888B1 (fr) |
CN (1) | CN1148172C (fr) |
AR (1) | AR019715A1 (fr) |
AT (1) | ATE215819T1 (fr) |
AU (1) | AU768755B2 (fr) |
BR (1) | BR9912210A (fr) |
CA (1) | CA2335582C (fr) |
CZ (1) | CZ300707B6 (fr) |
DE (2) | DE19828273B4 (fr) |
DK (1) | DK1089719T3 (fr) |
ES (1) | ES2177290T3 (fr) |
HU (1) | HUP0102498A3 (fr) |
IL (2) | IL140434A0 (fr) |
NZ (1) | NZ509015A (fr) |
PL (1) | PL193080B1 (fr) |
PT (1) | PT1089719E (fr) |
TR (1) | TR200003839T2 (fr) |
TW (1) | TW533084B (fr) |
WO (1) | WO1999066901A2 (fr) |
ZA (1) | ZA200007751B (fr) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19814084B4 (de) * | 1998-03-30 | 2005-12-22 | Lts Lohmann Therapie-Systeme Ag | D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung |
DE10025971B4 (de) * | 2000-05-25 | 2004-09-02 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System in Plasterform mit verminderter Tendenz zur Wirkstoffkristallisation und seine Verwendung |
US20030026830A1 (en) * | 2001-05-08 | 2003-02-06 | Thomas Lauterback | Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine |
US20030027793A1 (en) * | 2001-05-08 | 2003-02-06 | Thomas Lauterback | Transdermal treatment of parkinson's disease |
US6750291B2 (en) * | 2002-04-12 | 2004-06-15 | Pacific Corporation | Film-forming agent for drug delivery and preparation for percutaneous administration containing the same |
US8246979B2 (en) * | 2002-07-30 | 2012-08-21 | Ucb Pharma Gmbh | Transdermal delivery system for the administration of rotigotine |
US8211462B2 (en) * | 2002-07-30 | 2012-07-03 | Ucb Pharma Gmbh | Hot-melt TTS for administering rotigotine |
DE10234673B4 (de) * | 2002-07-30 | 2007-08-16 | Schwarz Pharma Ag | Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren |
US8246980B2 (en) * | 2002-07-30 | 2012-08-21 | Ucb Pharma Gmbh | Transdermal delivery system |
US20040086551A1 (en) | 2002-10-30 | 2004-05-06 | Miller Kenneth J. | Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl |
DK1426049T3 (da) * | 2002-12-02 | 2005-08-22 | Sanol Arznei Schwarz Gmbh | Iontophoretisk tilförsel af rotigotin til behandling af Parkinsons sygdom |
DE10261696A1 (de) * | 2002-12-30 | 2004-07-15 | Schwarz Pharma Ag | Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base |
US20080226698A1 (en) * | 2007-03-16 | 2008-09-18 | Mylan Technologies, Inc. | Amorphous drug transdermal systems, manufacturing methods, and stabilization |
US20080286348A1 (en) * | 2007-05-16 | 2008-11-20 | Todhunter John A | Secured transdermal delivery system |
WO2009107478A1 (fr) * | 2008-02-27 | 2009-09-03 | 久光製薬株式会社 | Timbre transdermique adhésif et produit conditionné |
EP2255809B1 (fr) * | 2008-02-27 | 2017-08-23 | Hisamitsu Pharmaceutical Co., Inc. | Timbre médicamenteux |
EP2286814B1 (fr) | 2008-05-15 | 2013-10-16 | Hisamitsu Pharmaceutical Co., Inc. | Préparation transdermique contenant de la palonosétrone |
US8366600B2 (en) * | 2008-06-19 | 2013-02-05 | Nupathe Inc. | Polyamine enhanced formulations for triptan compound iontophoresis |
CN103933018A (zh) * | 2013-01-18 | 2014-07-23 | 江苏康倍得药业有限公司 | 一种透皮给药系统 |
KR20180121352A (ko) | 2017-04-28 | 2018-11-07 | 닛토덴코 가부시키가이샤 | 경피 흡수형 제제 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0745400B2 (ja) * | 1986-03-29 | 1995-05-17 | 日東電工株式会社 | 外用医薬製剤 |
US4954343A (en) * | 1986-03-29 | 1990-09-04 | Nitto Electric Industrial Co., Ltd. | Dermal pharmaceutical preparations |
DE3743946A1 (de) | 1987-09-01 | 1989-03-09 | Lohmann Gmbh & Co Kg | Vorrichtung zur abgabe von nitroglycerin an die haut, verfahren zu ihrer herstellung sowie ihre verwendung |
US5474783A (en) * | 1988-03-04 | 1995-12-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
JP2857882B2 (ja) * | 1988-11-02 | 1999-02-17 | 富山化学工業株式会社 | ピロキシカムのプラスター剤 |
DE3933460A1 (de) | 1989-10-06 | 1991-04-18 | Lohmann Therapie Syst Lts | Oestrogenhaltiges wirkstoffpflaster |
DE3939376C1 (fr) * | 1989-11-29 | 1991-05-08 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg, 5450 Neuwied, De | |
GB9021674D0 (en) * | 1990-10-05 | 1990-11-21 | Ethical Pharma Ltd | Transdermal device |
JPH04261119A (ja) * | 1991-02-13 | 1992-09-17 | Lintec Corp | 経皮吸収型貼付剤 |
CA2077369A1 (fr) * | 1991-09-09 | 1993-03-10 | Hitoshi Akemi | Gel acrylique et preparation medicale a base de gel pour absorption percutanee |
US5676968A (en) * | 1991-10-31 | 1997-10-14 | Schering Aktiengesellschaft | Transdermal therapeutic systems with crystallization inhibitors |
US5286810A (en) * | 1992-08-07 | 1994-02-15 | Srchem Incorporated | Salt of polymer from maleic acid, polyamind and ammonia |
DE4230588C1 (de) * | 1992-09-12 | 1993-10-07 | Lohmann Therapie Syst Lts | Dexpanthenol-haltiges Pflaster zur transdermalen Applikation von Steroidhormonen und Verfahren zu seiner Herstellung |
DE4238223C1 (de) * | 1992-11-12 | 1994-05-26 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System zur Verabreichung von Physostigmin an die Haut und Verfahren zu dessen Herstellung |
DE4309830C1 (de) * | 1993-03-26 | 1994-05-05 | Lohmann Therapie Syst Lts | Wirkstoffpflaster für die Abgabe von Estradiol an die Haut |
DE4310012A1 (de) * | 1993-03-27 | 1994-09-29 | Roehm Gmbh | Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung |
JP3489831B2 (ja) * | 1993-04-20 | 2004-01-26 | ヘクサル・アクチエンゲゼルシャフト | 活性成分パッチ |
DE4336557C2 (de) | 1993-05-06 | 1997-07-17 | Lohmann Therapie Syst Lts | Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung |
DE4333595A1 (de) * | 1993-10-01 | 1995-04-06 | Labtec Gmbh | Transdermales therapeutisches System zur Applikation von Arzneimitteln auf die Haut |
DE4405898A1 (de) * | 1994-02-18 | 1995-08-24 | Schering Ag | Transdermale therapeutische Systeme enthaltend Sexualsteroide |
WO1995030409A1 (fr) | 1994-05-05 | 1995-11-16 | Merck Frosst Canada Inc. | Systeme d'administration topique de medicaments a matrice polymere |
US5906830A (en) * | 1995-09-08 | 1999-05-25 | Cygnus, Inc. | Supersaturated transdermal drug delivery systems, and methods for manufacturing the same |
DE19548332A1 (de) * | 1995-12-22 | 1997-07-10 | Rotta Res Bv | Hormonpflaster |
DE19701949A1 (de) * | 1997-01-13 | 1998-07-16 | Jenapharm Gmbh | Transdermales therapeutisches System |
US5951999A (en) * | 1997-02-21 | 1999-09-14 | Adhesives Research, Inc. | Transdermal pressure sensitive adhesive drug delivery system |
DE19728517C2 (de) * | 1997-07-04 | 1999-11-11 | Sanol Arznei Schwarz Gmbh | TTS zur Verabreichung von Sexualsteroidhormonen und Verfahren zu seiner Herstellung |
-
1998
- 1998-06-25 DE DE19828273A patent/DE19828273B4/de not_active Expired - Fee Related
-
1999
- 1999-06-08 AT AT99927904T patent/ATE215819T1/de active
- 1999-06-08 KR KR1020007014673A patent/KR100550888B1/ko not_active IP Right Cessation
- 1999-06-08 EP EP99927904A patent/EP1089719B1/fr not_active Expired - Lifetime
- 1999-06-08 WO PCT/EP1999/003922 patent/WO1999066901A2/fr active IP Right Grant
- 1999-06-08 AU AU45086/99A patent/AU768755B2/en not_active Ceased
- 1999-06-08 US US09/720,287 patent/US6899894B1/en not_active Expired - Fee Related
- 1999-06-08 HU HU0102498A patent/HUP0102498A3/hu unknown
- 1999-06-08 DK DK99927904T patent/DK1089719T3/da active
- 1999-06-08 TR TR2000/03839T patent/TR200003839T2/xx unknown
- 1999-06-08 CZ CZ20004798A patent/CZ300707B6/cs not_active IP Right Cessation
- 1999-06-08 DE DE59901202T patent/DE59901202D1/de not_active Expired - Lifetime
- 1999-06-08 PL PL345455A patent/PL193080B1/pl not_active IP Right Cessation
- 1999-06-08 CN CNB998088706A patent/CN1148172C/zh not_active Expired - Fee Related
- 1999-06-08 JP JP2000555587A patent/JP2002518430A/ja active Pending
- 1999-06-08 PT PT99927904T patent/PT1089719E/pt unknown
- 1999-06-08 IL IL14043499A patent/IL140434A0/xx active IP Right Grant
- 1999-06-08 NZ NZ509015A patent/NZ509015A/en not_active IP Right Cessation
- 1999-06-08 ES ES99927904T patent/ES2177290T3/es not_active Expired - Lifetime
- 1999-06-08 CA CA002335582A patent/CA2335582C/fr not_active Expired - Fee Related
- 1999-06-08 BR BR9912210-3A patent/BR9912210A/pt not_active Application Discontinuation
- 1999-06-22 TW TW088110455A patent/TW533084B/zh not_active IP Right Cessation
- 1999-06-25 AR ARP990103056A patent/AR019715A1/es active IP Right Grant
-
2000
- 2000-12-20 IL IL140434A patent/IL140434A/en not_active IP Right Cessation
- 2000-12-21 ZA ZA200007751A patent/ZA200007751B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
IL140434A0 (en) | 2002-02-10 |
ATE215819T1 (de) | 2002-04-15 |
PL193080B1 (pl) | 2007-01-31 |
AU4508699A (en) | 2000-01-10 |
BR9912210A (pt) | 2001-04-10 |
DE59901202D1 (de) | 2002-05-16 |
IL140434A (en) | 2006-10-05 |
CA2335582C (fr) | 2006-04-11 |
DE19828273A1 (de) | 1999-12-30 |
KR20010053132A (ko) | 2001-06-25 |
WO1999066901A3 (fr) | 2000-03-23 |
ZA200007751B (en) | 2001-07-18 |
AR019715A1 (es) | 2002-03-13 |
AU768755B2 (en) | 2004-01-08 |
WO1999066901A2 (fr) | 1999-12-29 |
HUP0102498A2 (hu) | 2001-11-28 |
TR200003839T2 (tr) | 2001-06-21 |
EP1089719B1 (fr) | 2002-04-10 |
US6899894B1 (en) | 2005-05-31 |
CN1310616A (zh) | 2001-08-29 |
CA2335582A1 (fr) | 1999-12-29 |
DE19828273B4 (de) | 2005-02-24 |
TW533084B (en) | 2003-05-21 |
HUP0102498A3 (en) | 2002-01-28 |
PL345455A1 (en) | 2001-12-17 |
NZ509015A (en) | 2004-01-30 |
KR100550888B1 (ko) | 2006-02-10 |
ES2177290T3 (es) | 2002-12-01 |
CN1148172C (zh) | 2004-05-05 |
PT1089719E (pt) | 2002-09-30 |
CZ20004798A3 (en) | 2001-05-16 |
CZ300707B6 (cs) | 2009-07-22 |
JP2002518430A (ja) | 2002-06-25 |
EP1089719A2 (fr) | 2001-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1089719T3 (da) | Transdermalt terapeutisk system indeholdende hormoner og krystallisationsinhibitorer | |
DE69713989D1 (de) | Fentanyl enthaltendes transdermal-pflaster | |
GB9720470D0 (en) | Inhibition of crystallization in transdermal devices | |
DK0811006T3 (da) | Benzopyranholdige forbindelser og fremgangsmåde til deres anvendelse | |
DK1105123T3 (da) | Farmaceutiske præparater indeholdende lipase-inhibitorer og chitosan | |
NO20001323D0 (no) | Dipeptid-apoptose inhibitorer og deres anvendelse | |
NO980687L (no) | System og fremgangsmåte for perfusjon-hypertermibehandling | |
NO20021401D0 (no) | Konazolinforbindelser og farmasöytiske preparater inneholdende slike forbindelser | |
NO993680D0 (no) | Forankringsanordning og fremgangsmåte | |
NO20012289L (no) | Anordning og fremgangsmåte for innretting | |
NO20003067D0 (no) | Antipicornavirus-forbindelser og fremgangsmÕter for deres anvendelse og fremstilling | |
DK1242012T3 (da) | Forbedret transdermalt præventionsmiddelafgivelsessystem og fremgangsmåde | |
NO20000188D0 (no) | Fremgangsmåte og anordning for sidebroenntilknytning | |
DK0939659T3 (da) | Anordning til transdermal elektrotransportafgivelse af fentanyl og sufentanil | |
NO993731L (no) | Pyrrolopyrazolopyrimidin-forbindelse og medisin omfattende denne | |
DK1164996T3 (da) | Transdermalt terapeutisk system med nikotin og tilsat monoterpenketoner | |
NO20014283D0 (no) | Anordning for krystallisasjon og fremgangsmåte for krystallisasjon | |
NO991278L (no) | FremgangsmÕte og system for sikker netthandel | |
NO20000371D0 (no) | Aminoetylfenoksyeddiksyrederivater og legemidler for smertereduksjon og kalksteinfjerningsfremming i urin litiasis | |
NO993435D0 (no) | Transdermalt acetylsalicylsyre inneholdende terapeutisk system med forsterket resorpsjon | |
DK1228026T3 (da) | 15-Hydroxyicosatetraensyrerelaterede forbindelser og fremgangsmåde til anvendelse | |
DK1078458T3 (da) | Timingindretning og timingfremgangsmåde | |
NO20023028L (no) | Substituerte pyrrol-mannich baser for bekjemping av smerter og allergiske reaksjoner | |
NO965551D0 (no) | Chirale forbindelser og opplösning derav | |
DK1244662T3 (da) | Pyridazinoquinolinderivater og fremgangsmåde til behandling af smerter |